Zyprexa Lawsuit Funding

Zyprexa Settlement Loans

Of the six atypical antipsychotic medications approved by the FDA for use in the United States, Zyprexa is the most commonly prescribed. Zyprexa has been prescribed to more than 14 million people in 84 countries since 1996.

In September 2003, the FDA ordered Eli Lilly, the drug's manufacturer, to revise Zyprexa's label by adding a side effects warning that "hyperglycemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients treated with atypical anti-psychotics." Other Zyprexa side effects can include diabetes, diabetic coma, diabetic ketoacidosis, hyperglycemia, hyperosmolar coma and death.

100% RISK-FREE LAWSUIT LOANS & PRE SETTLEMENT CASH ADVANCES!
Our Zyprexa settlement funding is "non-recourse". That means if you lose your case or it doesn't settle, you keep the money we advanced and owe us NOTHING!
It's as simple as that.

Zyprexa Lawsuit

Eli Lilly, a world leader in diabetes research, prior to marketing the drug in the US, had knowledge that the side effects of Zyprexa included diabetes, pancreatitis and severe weight gain. Nevertheless, they made the profit-driven decision to market the drug in 1996 without proper warnings to patients or doctors of these severe side effects.

The Zyprexa lawsuit is based on allegations that the Zyprexa label in use prior to March 2004 contained inadequate warnings regarding the seriousness of potential side effects. Also, published reports indicate that as far back as the 1950's, studies tied the use of Zyprexa and similar drugs to an increased incidence of diabetes, pancreatitis, hyperglycemia and other serious conditions. It is alleged that Eli Lilly continued to market Zyprexa without adequate warnings, despite full knowledge of this vital information.

In February of 2004, the American Diabetes Association, the American Psychiatric Association, the North American Association for the Study of Obesity and the American Association of Clinical Endocrinologists issued a joint statement warning the public of the association between Zyprexa and serious weight gain, diabetes and pancreatitis.

Eli Lilly / Zyprexa Settlement

On January 14, 2009 Eli Lilly officially settled a portion of the Zyprexa lawsuit for $1.42 billion. Putting this into some context, Eli Lilly reportedly had Zyprexa sales in excess of $37 billion since the drug was first introduced, making it one of Eli Lilly’s biggest sellers.

In the meantime, it is becoming commonplace for people who have been injured by Zyprexa to find themselves in need of extra money due to loss of income from being out of work to pay for bills, medical care & basic living expenses. Pre settlement funding or a lawsuit cash advance can give plaintiffs the money they need now to get by until their full settlement comes through, whenever that may be.

Getting lawsuit funding or a pre settlement advance is simple and easy. It's fast, free and easy to apply and with no credit checks, no income or employment requirements, no monthly payments and no up-front or out-of-pocket costs, settlement loans are 100% RISK-FREE for plaintiffs and you only repay the advance if you win your case. If you lose your case or your case doesn't settle, YOU OWE US NOTHING!

THERE'S ZERO RISK ... SO WHY WAIT?

Does your Zyprexa settlement qualify for a lawsuit cash advance?
Find out now by calling us at 1-877-932-2628 or simply complete the info below.

Serving these cities & states: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington DC, West Virginia, Wisconsin and Wyoming. AL, AK, AZ, AR, CA, CO, CT, DC, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NC, ND, NE, NV, NH, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WI, WV & WY.